These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8680544)

  • 1. Serum hyaluronate in patients with acute and fulminant hepatitis.
    Suzuki K; Endo R; Takikawa Y; Nakadate I; Sato S
    J Gastroenterol; 1996 Apr; 31(2):237-41. PubMed ID: 8680544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Parameter in fulminant hepatitis].
    Moritoh T; Kuroda M; Takagi T; Ohkuma Y; Saitoh K
    Rinsho Byori; 1991 Jan; 39(1):34-40. PubMed ID: 2008037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum thyroid hormone levels in patients with fulminant hepatitis: usefulness of rT3 and the rT3/T3 ratio as prognostic indices.
    Kano T; Kojima T; Takahashi T; Muto Y
    Gastroenterol Jpn; 1987 Jun; 22(3):344-53. PubMed ID: 3114036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of serum soluble Fas ligand in patients with acute self-limited and fulminant hepatitis.
    Shiota G; Oyama K; Noguchi N; Takano Y; Kitaoka S; Kawasaki H
    Res Commun Mol Pathol Pharmacol; 1998 Jul; 101(1):3-12. PubMed ID: 9755839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial blood ketone body ratio as a possible indicator for predicting fulminant hepatitis in patients with acute hepatitis.
    Saibara T; Onishi S; Maeda T; Yamamoto Y
    Liver; 1992 Dec; 12(6):392-6. PubMed ID: 1470010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and urine levels of urinary trypsin inhibitor in patients with acute and fulminant hepatitis.
    Lin SD; Endo R; Sato A; Takikawa Y; Shirakawa K; Suzuki K
    J Gastroenterol Hepatol; 2002 Feb; 17(2):140-7. PubMed ID: 11966943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels and hepatic mRNA expression of transforming growth factor-beta1 in patients with fulminant hepatic failure.
    Miwa Y; Harrison PM; Farzaneh F; Langley PG; Williams R; Hughes RD
    J Hepatol; 1997 Nov; 27(5):780-8. PubMed ID: 9382963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity.
    Ramadori G; Zöhrens G; Manns M; Rieder H; Dienes HP; Hess G; Meyer KH; Büschenfelde Z
    Eur J Clin Invest; 1991 Jun; 21(3):323-30. PubMed ID: 1909636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of antithrombin III and alpha 2-plasmin inhibitor in early differentiation of fulminant hepatitis and severe form of acute hepatitis.
    Sato S; Murakami A; Yoshida T; Kashiwabara T; Suzuki K; Kaito I
    Gastroenterol Jpn; 1983 Apr; 18(2):128-36. PubMed ID: 6852439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay.
    Tsubouchi H; Niitani Y; Hirono S; Nakayama H; Gohda E; Arakaki N; Sakiyama O; Takahashi K; Kimoto M; Kawakami S
    Hepatology; 1991 Jan; 13(1):1-5. PubMed ID: 1824837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High levels of serum interleukin-10 and tumor necrosis factor-alpha are associated with fatality in fulminant hepatitis.
    Nagaki M; Iwai H; Naiki T; Ohnishi H; Muto Y; Moriwaki H
    J Infect Dis; 2000 Oct; 182(4):1103-8. PubMed ID: 10979906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients.
    Peters L; Mocroft A; Soriano V; Rockstroh J; Rauch A; Karlsson A; Knysz B; Pradier C; Zilmer K; Lundgren JD;
    PLoS One; 2013; 8(5):e64283. PubMed ID: 23724041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum interleukin-6 levels in patients with acute hepatitis.
    Sun Y; Tokushige K; Isono E; Yamauchi K; Obata H
    J Clin Immunol; 1992 May; 12(3):197-200. PubMed ID: 1400900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver regeneration in fulminant hepatitis as evaluated by serum transforming growth factor alpha levels.
    Tomiya T; Fujiwara K
    Hepatology; 1996 Feb; 23(2):253-7. PubMed ID: 8591849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group.
    McHutchison JG; Blatt LM; de Medina M; Craig JR; Conrad A; Schiff ER; Tong MJ
    J Gastroenterol Hepatol; 2000 Aug; 15(8):945-51. PubMed ID: 11022838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum hyaluronic acid as a marker of hepatic fibrosis.
    Khan JA; Khan FA; Dilawar M; Ijaz A; Khan NA; Mehmood T
    J Coll Physicians Surg Pak; 2007 Jun; 17(6):323-6. PubMed ID: 17623578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
    Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of plasma fibronectin in fulminant hepatitis: association with infection and mortality.
    Acharya SK; Dasarathy S; Irshad M
    J Hepatol; 1995 Jul; 23(1):8-13. PubMed ID: 8530814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prediction of hepatic fibrosis using serum hyaluronic acid in patients with chronic liver disease].
    Kim CW; Yoon SK; Jo BS; Shin JY; Jang JW; Choi JY; Han NI; Lee CD; Chung KW; Sun HS
    Korean J Gastroenterol; 2003 Dec; 42(6):510-8. PubMed ID: 14695708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum gamma-interferon-inducing factor (IL-18) and IL-10 levels in patients with acute hepatitis and fulminant hepatic failure.
    Yumoto E; Higashi T; Nouso K; Nakatsukasa H; Fujiwara K; Hanafusa T; Yumoto Y; Tanimoto T; Kurimoto M; Tanaka N; Tsuji T
    J Gastroenterol Hepatol; 2002 Mar; 17(3):285-94. PubMed ID: 11982699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.